Tumor-informed circulating tumor DNA (TI-ctDNA) based molecular residual disease (MRD) detection and relapse risk for patients with stage II-IV melanoma in surgical remission: A single center experience

被引：0
|
作者：
Rhea, Logan
Daniels, Megan
Sabo, Roy
Poklepovic, Andrew Stewart
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA
[2] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9572
引用
收藏
页数：1
相关论文
共 16 条
  • [1] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).
    Cao, Di
    Wang, Fu-Long
    Li, Cong
    Zhang, Rong-Xin
    Wu, Xiao-Jun
    Li, Liren
    Lu, Zhen-Hai
    Pan, Zhi-Zhong
    Lin, Jun-zhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Li, Min
    Wang, Chenyang
    Li, Xi
    Chen, Gong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 213 - 213
  • [3] Feasibility of tumor-informed circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment in pediatric patients with solid tumors.
    Mitchell, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [5] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in stage 1-3 colorectal cancer (CRC) in clinical practice
    Somer, B.
    Mehler, S.
    Hasenburg, A.
    Greene, H.
    Tauer, K.
    Grothey, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S347 - S347
  • [6] Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes
    Zhong, R.
    Liang, H.
    Jiang, Y.
    Lin, Y.
    Fu, W.
    Xiong, Y.
    Xiong, S.
    Wang, R.
    Ye, Z.
    Li, X.
    Li, J.
    Li, F.
    Wang, H.
    Xiang, Y.
    Yu, Z.
    Zhan, S.
    Chen, P.
    Zheng, X.
    Liang, W.
    He, J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S735 - S735
  • [7] Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
    Cohen, S.
    Hook, N.
    Krinshpun, S.
    Westbrook, L.
    Loranger, K.
    Wallace, J.
    Aleshin, A.
    Billings, P.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S229 - S229
  • [8] Detection of molecular residual disease in stage II and III melanoma utilizing circulating tumor DNA.
    Chen, Emily
    Brunsgaard, Elise Kornreich
    Kuzel, Timothy
    Tan, Alan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma
    Kollipara, Revathi
    Budde, Griffin
    Aushev, Vasily N.
    Brunsgaard, Elise Kornreich
    Kuzel, Timothy
    O'Donoghue, Cristina
    Riddell, Timothy
    Palsuledesai, Charuta C.
    Krainock, Michael
    Liu, Minetta C.
    Tan, Alan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Leveraging personalized circulating tumor DNA (ctDNA) for detection and monitoring of molecular residual disease in high-risk melanoma.
    Genta, Sofia
    Araujo, Daniel Vilarim
    Keshavarzi, Sareh
    Muniz, Thiago Pimentel
    Kamil, Zaid Saeed
    Howarth, Karen
    Terrell, Samantha
    Joad, Andy
    Ventura, Robert
    Covelli, Andrea
    Saibil, Samuel
    Spiliopoulou, Pavlina
    Vornicova, Olga
    Easson, Alexandra Maria
    Butler, Marcus O.
    Siu, Lillian L.
    Bratman, Scott Victor
    Spreafico, Anna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12